The interaction of podoplanin with the tetraspanin CD9 is mediated by CD9 transmembrane domains 1 and 2, and this interaction impairs cancer metastasis by inhibiting platelet aggregation (Nakazawa et al., 2008). Here, CD9 is linked to cancer.